MOEXIPRIL HYDROCHLORIDE POWDER >=98% (HPLC) (C005B-454985)

Catalog No.: C005B-454985
Mfr. No.: M0821-100MG
Mfr. Name: Sigma-Aldrich
Qty/UOM: 100
UOM: MG

Price: $815.80

List Price: $906.44

Biochem/physiol Actions Moexipril is an ACE-Inhibitor: Antihypertensive: Unlike other ACE inhibitors, prolongs QT interval leading to torsades de pointes and cardiad arrhythmia: Features and Benefits This compound is featured on the

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

Biochem/physiol Actions

Moexipril is an ACE-Inhibitor; Antihypertensive; Unlike other ACE inhibitors, prolongs QT interval leading to torsades de pointes and cardiad arrhythmia;

Features and Benefits

This compound is featured on the Angiotensin Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.

This compound was developed by UCB Inc.. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

UPC:: 51433407
Condition:: New
Availability:: 3-5 Days
Weight:: 1.00 Ounces
HazmatClass:: No
MPN:: M0821-100MG
CAS:: 82586-52-5

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."